Context Capital Management’s Clarus Therapeutics Holdings, Inc. Warrants CRXTW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-62,175
Closed 630
2022
Q3
$0 Hold
62,175
﹤0.01% 641
2022
Q2
$5K Hold
62,175
﹤0.01% 569
2022
Q1
$9K Sell
62,175
-25,000
-29% -$4.54K ﹤0.01% 657
2021
Q4
$25K Sell
87,175
-30,136
-26% -$15.4K ﹤0.01% 516
2021
Q3
$88K Buy
117,311
+5,965
+5% +$4.5K 0.01% 381
2021
Q2
$84K Sell
111,346
-5,400
-5% -$3.39K 0.01% 439
2021
Q1
$64K Buy
+116,746
New +$93.4K 0.01% 415